Decreased prevalence of Alzheimer’s disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors - Wolozin,B.; Kellman,W.; Ruosseau,P.; Celesia,G.-G.; Siegel,G. (Arch Neurol, 2000)